Share this
Protenus Granted Three New Patents for Patient Privacy Monitoring and Drug Diversion Surveillance Technologies
by Protenus on Sep 13, 2022 9:32:20 AM
Further delivering on its fundamental commitment to innovation, Protenus is pleased to announce the grant of three new patents to protect the intellectual property of its patient privacy monitoring and drug diversion surveillance technologies. Protenus now holds a number of granted US patents covering various key aspects of patient privacy monitoring and drug diversion surveillance technologies, along with several other pending US and foreign patent applications.
U.S. Patent Nos. 11,437,126 and 11,437,128, issued on September 6,2022, which are both titled “Methods and Systems for Analyzing Accessing of Medical Data.” With these patents, Protenus now holds a number of granted US patents covering various techniques for determining patient data access events that constitute possible breaches of patient data. For example, the newly-granted patents cover numerous techniques including: retrieving EMR access data and HR data, determining patterns of access events, applying a filter to access data to prevent excessive false positives, and displaying alerts related to possible breaches, among other things.
Protenus is also pleased to announce the recent grant of US Patent No. 11,437,131 titled “Methods and Systems for Analyzing Accessing of Drug Dispensing Systems.” With this patent, Protenus also now holds a number of granted US patents covering various techniques for detecting anomalous drug dispensing events. For example, the newly-granted patent covers numerous techniques including: clustering dispensing events into groups, determining dispensing patterns, and displaying alerts for outlier dispensing events, among other things.
Any licensing inquiries or other questions about Protenus’ patent portfolio should be directed to Protenus General Counsel, Amy Much at amy.much@protenus.com.
About Protenus
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do.
Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.
Media Contact
Amanda Rogers
Marketing Content Writer
amanda.rogers@protenus.com
Share this
- July 2024 (1)
- May 2024 (1)
- April 2024 (2)
- March 2024 (2)
- February 2024 (1)
- October 2023 (1)
- June 2023 (1)
- May 2023 (2)
- March 2023 (1)
- February 2023 (2)
- December 2022 (2)
- November 2022 (1)
- September 2022 (1)
- July 2022 (1)
- June 2022 (3)
- April 2022 (3)
- March 2022 (4)
- November 2021 (1)
- August 2021 (2)
- July 2021 (1)
- June 2021 (4)
- May 2021 (2)
- April 2021 (1)
- March 2021 (3)
- February 2021 (1)
- September 2020 (1)
- August 2020 (2)
- July 2020 (1)
- April 2020 (1)
- March 2020 (2)
- February 2020 (1)
- January 2020 (3)
- December 2019 (1)
- November 2019 (1)
- October 2019 (2)
- September 2019 (1)
- August 2019 (2)
- July 2019 (1)
- May 2019 (5)
- April 2019 (2)
- March 2019 (1)
- February 2019 (3)
- January 2019 (2)
- December 2018 (1)
- October 2018 (2)
- September 2018 (8)
- August 2018 (1)
- July 2018 (2)
- June 2018 (10)
- May 2018 (4)
- April 2018 (3)
- March 2018 (2)
- February 2018 (1)
- January 2018 (2)
- December 2017 (2)
- November 2017 (6)
- October 2017 (1)
- September 2017 (2)
- August 2017 (3)
- July 2017 (4)
- June 2017 (1)
- May 2017 (1)
- March 2017 (1)
- October 2016 (2)
- September 2016 (1)
- April 2016 (1)
- February 2016 (1)